首页|基于红外热成像技术评价消癥饮联合精前康抑菌凝胶治疗湿热瘀阻型慢性前列腺炎的临床疗效

基于红外热成像技术评价消癥饮联合精前康抑菌凝胶治疗湿热瘀阻型慢性前列腺炎的临床疗效

扫码查看
目的:通过红外热成像技术评价消癥饮联合精前康抑菌凝胶对湿热瘀阻型慢性前列腺炎的临床疗效.方法:纳入于河南中医药大学第一附属医院男科门诊就诊的120 例湿热瘀阻型慢性前列腺炎患者,随机分为试验组和对照组(各60 例),试验组给予消癥饮颗粒口服联合精前康抑菌凝胶纳肛;对照组予消癥饮颗粒口服,疗程均为4 周.分别于治疗前后对两组患者NIH-CPSI评分、中医证候积分以及带脉区、下焦区、腹股沟区域红外热成像温度数据进行测定,并观察两组患者在治疗期间出现的不良反应情况.结果:治疗后两组患者NIH-CPSI评分和中医证候积分较治疗前均明显下降(P<0.05),且试验组下降程度高于对照组(P<0.05).治疗 1h后,试验组下焦[(33.60±0.40)℃]及腹股沟[(33.78±0.30)℃]区域温度较治疗前[下焦:(34.09±0.34)℃,腹股沟:(34.49±0.28)℃]均降低(P<0.05),对照组[治疗前:下焦:(34.02±0.29)℃,腹股沟:(34.54±0.25)℃,治疗1h后:下焦:(34.05±0.26)℃,腹股沟:(34.51±0.22)℃]无明显变化(P>0.05);治疗4 周后,两组患者下焦区[试验组:(33.13±0.41)℃,对照组:(33.42±0.25)℃]及腹股沟[试验组:(33.21±0.29)℃,对照组:(33.86±0.29)℃]区域温度较治疗前[试验组:下焦:(34.09±0.34)℃,腹股沟:(34.49±0.28)℃,对照组:下焦:(34.02±0.29)℃,腹股沟:(34.54±0.25)℃]及治疗1h后均降低(P<0.05),且试验组低于对照组(P<0.05).试验组总有效率(88.14%)优于对照组(77.19%)(P<0.05),两组均未见明显不良反应.结论:消癥饮联合精前康抑菌凝胶能够明显降低湿热瘀阻型慢性前列腺炎患者NIH-CPSI评分、中医证候积分和下焦区及腹股沟区域红外热成像热值,安全性良好,值得临床推广和使用.
Xiaozheng Granules combined with Jingqiankang Bacteriostatic Gelatin for chronic prostatitis with damp-heat and blood stasis:A clinical observation based on infrared thermography
Objective:To evaluate the clinical efficacy of Xiaozheng Granules(XZG)combined with Jingqiankang Bacterio-static Gelatin(JBG)on chronic prostatitis of the damp-heat and blood-stasis type based on infrared thermography(IRT).Methods:This study included 120 cases of chronic prostatitis with damp-heat and blood stasis treated in the First Affiliated Hospital of Henan U-niversity of Chinese Medicine with oral XZG(the control group,n=60)or oral XZG combined with anal administration of JBG(the trial group,n=60),both for 4 weeks.We obtained the NIH-CPSI and traditional Chinese medicine(TCM)syndrome scores of the patients,measured the temperatures in the belt-vessel,lower focal and inguinal regions by IRT before and after treatment,recorded the adverse reactions during the treatment,and compared them between the two groups of patients.Results:Compared with the base-line,the NIH-CPSI and TCM syndrome scores were significantly decreased in the two groups of patients after treatment(P<0.05),even more significantly in the trial than in the control group(P<0.05),and after 1 hour of treatment,the temperatures in the Xia-jiao([34.09±0.34]vs[33.60±0.40]℃,P<0.05)and the groin region([34.49±0.28]vs[33.78±0.30]℃,P<0.05)were remarkably reduced in the trial group,but showed no significant change in the control group(Xiajiao region:[34.02±0.29]vs[34.05±0.26]℃,P>0.05;groin region:[34.54±0.25]vs[34.51±0.22]℃,P>0.05).After 4 weeks of treatment,the temperatures in the Xiajiao and groin regions were even lower in the trial([33.13±0.41]℃ and[33.21±0.29]℃ )and the control group([33.42±0.25]℃ and[33.86±0.29]℃ )than the baseline and those after 1 hour of treatment(P<0.05),and still more significantly in the former than in the latter group(P<0.05).The total effectiveness rate was markedly higher in the trial group than in the control(88.14% vs 77.19%,P<0.05),and no obvious adverse reactions were observed in neither group.Conclusion:XZG combined with JBG is a safe and effective treatment of chronic prostatitis with damp-heat and blood-stasis,which can significantly reduce the NIH-CPSI and TCM syndrome scores and IRT temperatures in the lower focal and in-guinal regions of the patients.

infrared thermographyXiaozheng GranulesJingqiankang Bacteriostatic Gelatinchronic prostatitisdamp-heat and blood stasis

马鹏、张琦、常贵峰、王祖龙

展开 >

河南中医药大学第一临床医学院,河南 郑州 450046

河南中医药大学第一附属医院男科,河南 郑州 450003

红外热成像 消癥饮 精前康 慢性前列腺炎 湿热瘀阻

国家自然科学基金国家卫生健康委医药卫生科技发展研究中心项目

82174377HDS202001076

2024

中华男科学杂志
南京军区南京总医院

中华男科学杂志

CSTPCD
影响因子:1.052
ISSN:1009-3591
年,卷(期):2024.30(6)
  • 17